540222:BOM
Laurus Labs Ltd
2.036,00 INR
arrow_downward
-0,74%(-15,10) 1G
14 ott, 15:30:00 GMT+5:30 · INR
search
Tutti i simboli
| Simbolo | Prezzo | Cambio | % di cambio |
|---|
insights_autoGenerazione degli insight principali per 540222 in corso…
Apertura
2.051,95 INR
Massimo
2.051,95 INR
Minimo
2.019,05 INR
Cap. mercato
1,10 Bln
Vol. medio
88,52K
Volume
43,56K
Dividendo
0,10%
Dividendo trimestrale
0,50 INR
Data di stacco dividendo
8 mag 2026
Rapporto P/E
100,67
Max 52 sett.
2.071,00 INR
Min 52 sett.
865,00 INR
Utili per azione
20,23 INR
Azioni in circolazione
106,44 Mln
N. di dipendenti
7K
Apertura
2.051,95 INR
Massimo
2.051,95 INR
Minimo
2.019,05 INR
Cap. mercato
1,10 Bln
Vol. medio
88,52K
Volume
43,56K
Dividendo
0,10%
Dividendo trimestrale
0,50 INR
Data di stacco dividendo
8 mag 2026
Rapporto P/E
100,67
Max 52 sett.
2.071,00 INR
Min 52 sett.
865,00 INR
Utili per azione
20,23 INR
Azioni in circolazione
106,44 Mln
N. di dipendenti
7K
Articoli giornalistici
Da fonti web e partner giornalistici
Kalkine India
·
1 giorno fa
Laurus Labs Q2 H1 FY27 Earnings Conference Call Date
Profilo
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
Informazioni su Laurus Labs Ltd